New Eye Drop Treatment for Diabetic Retinopathy to Begin Advanced Testing
Exonate, a pharmaceutical company, has announced plans to start a phase 2b clinical trial for its lead drug, EXN407, in […]
New FDA Leader Brings Biotech Experience and Controversial Views to Drug Review Division
Dr. George Tidmarsh, a physician, academic, and biotech entrepreneur, has been appointed as the new director of the FDA’s Center
New Immunotherapy Combo Approved for Advanced Liver Cancer in the UK
AstraZeneca has received a positive recommendation from NICE (the National Institute for Health and Care Excellence) for a new combination
Trump Warns Drug Companies to Lower Prices or Face Government Action
President Donald Trump has warned 17 major drug companies that they must lower their prices to match those in other
President Trump Pressures Drug Companies to Lower Prices Under ‘Most Favored Nation’ Policy
President Trump has sent letters to major drug companies, urging them to lower prices in the U.S. to match the
New Drug Trial Begins for Severe Heart Condition
4TEEN4 Pharmaceuticals has started testing a new drug called procizumab in patients with cardiogenic shock, a life-threatening condition where the
Pharmaceutical News
UK-India Trade Deal and Key Updates in Healthcare and Pharma
A new £4.8 billion ($6.45 billion) free trade agreement (FTA) between the UK and India is expected to create new
Biotech IPOs Face New Challenges in 2025 and Beyond
After a slow recovery in 2024, biotech companies looking to go public in 2025 may face more obstacles. While only
TCG Labs Soleil Raises $400 Million to Launch New Drug Companies
TCG Labs Soleil, a company that creates focused biotechnology startups and prepares them for partnerships, announced on Thursday that it
European Regulators Reject Sarepta’s Duchenne Muscular Dystrophy Gene Therapy
The European Medicines Agency (EMA) has recommended against approving Sarepta’s gene therapy, Elevidys, for Duchenne muscular dystrophy (DMD) after a